Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort studyMarlies Kempers, Marjolijn J. L. Ligtenberg, Verena Steinke et al.|The Lancet Oncology|2010Cited by 293
Identification of Novel Genetic Markers of Breast Cancer SurvivalQi Guo, Carmel Apicella, Marjanka K. Schmidt et al.|JNCI Journal of the National Cancer Institute|2015Cited by 244
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriersEsther H. Lips, Petra M. Nederlof, Lennart Mulder et al.|British Journal of Cancer|2013Cited by 241
<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGSMelissa C. Southey, Robert Winqvist, Katri Pylkäs et al.|Journal of Medical Genetics|2016Cited by 217